Skip to main content
Erschienen in: Cardiovascular Ultrasound 1/2014

Open Access 01.12.2014 | Research

Transcranial doppler ultrasonography should it be the first choice for persistent foramen ovale screening?

verfasst von: Monika Komar, Maria Olszowska, Tadeusz Przewłocki, Jakub Podolec, Jakub Stępniewski, Bartosz Sobień, Rafał Badacz, Anna Kabłak-Ziembicka, Lidia Tomkiewicz-Pająk, Piotr Podolec

Erschienen in: Cardiovascular Ultrasound | Ausgabe 1/2014

Abstract

Background

Persistent foramen ovale (PFO) is considered a cause of cryptogenic stroke and a risk factor for neurological events in young patients. The reference standard for identifying a PFO is contrast-enhanced transesophageal echocardiography (TEE).
The goal of this study was to evaluate the feasibility of transcranial color Doppler (TCD) and its diagnostic sensitivity compared with TEE.

Methods

We investigated 420 patients admitted to our department with cryptogenic stroke, transient ischemic attacks or other neurological symptoms. All patients underwent TCD and TEE evaluation. TCD and TEE examinations were performed according to a standardized procedure: air-mixed saline was injected into the right antecubital vein three times, while the Doppler signal was recorded during the Valsalva maneuver. During TCD the passage of contrast into the right-middle cerebral artery was recorded 25 seconds following the Valsalva maneuver.

Results

We detected a right-to-left shunt in 220 patients (52.3%) and no-shunts in 159 patients (37.9%) with both TCD and TEE. In 20 (4.8%) patients TEE did not reveal contrast passage which was then detected by TCD. In 21 (5.0%) patients only TEE revealed a PFO. The feasibility of both methods was 100%. TCD had a sensitivity of 95% and a specificity of 92% in the diagnosis of PFO.

Conclusions

TCD has a relatively good sensitivity and specificity. TCD and TEE are complementary diagnostic tests for PFO, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost and high feasibility.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1476-7120-12-16) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MK: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. MO: contributed to study conception and design, helped to draft the manuscript, revising it critically. TP: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content, gave final approval of the version to be published. JP: contributed to study conception and design, analysis and interpretation of data. JS: analysis and interpretation of data, drafting the manuscript. BS: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript. RB: contributed in revising critically for important intellectual content. AKZ: analysis and interpretation of data, revising it critically for important intellectual content. LTP: contributed in acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. PP: contributed to study conception and design, revising it critically for important intellectual content, gave final approval of the version to be published. All author’s read approved the final manuscript.
Abkürzungen
MBs
Micro bubbles
MCA
Middle cerebral artery
NPV
Negative predictive value
PFO
Persistent foramen ovale
PPV
Positive predictive value
RLS
Right to left shunt
TCD
Transcranial color doppler
TEE
Transesophageal echocardiography
TIA
Transient ischaemic attack
TTE
Transthoracic echocardiography.

Background

Persistent foramen ovale (PFO) is considered a cause of cryptogenic stroke and a risk factor for neurological events in patients under 40 years of age. PFO has been also associated with several disease processes such as arterial gas embolism due to decompression, or platypnea-orthodeoxia syndrome [14]. Although the clinical significance of PFO in relation to cryptogenic stroke is still debated, identification and assessment of this abnormality are nowadays a routine diagnostic procedure.
Agitated saline serum has been used in transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and transcranial color Doppler ultrasound (TCD) for the detection of intracardiac shunts. The reference standard for identifying a PFO is contrast-enhanced TEE but it is a semi-invasive, inconvenient and stressful for the patients and also quite expensive procedure.
Some studies have analyzed the most suitable strategy for the screening, diagnosis and quantification of PFO [58]. The aim of this study was to evaluate the feasibility of transcranial Doppler and its diagnostic sensitivity compared with transesophageal echocardiography.

Methods

Patient population

We investigated 420 consecutive patients [(260 females, 160 males); mean age 34.8 ± 16.7 (13, 65) years] admitted to our department with cryptogenic stroke, transient ischaemic attacks (TIA) or other neurological symptoms between 2007 and 2014. Most patients (over 50%) had a history of TIA. The main demographic characteristics of the patients are summarized in Table 1.
Table 1
Demographic characteristics of the patients
 
Patients (n = 420)
Smoking
205 (48.8%)
Obesity
72 (17.4%)
Diabetes mellitus
19 (4.5%)
Hypertension
64 (15.2%)
Dyslipidemia
29 (6.9%)

Protocol

All patients underwent TCD and TEE evaluation. The studies were performed on the same day by two different experienced cardiologists, unaware with respect to the result of the other study. The patients were examined in the fasting state. Written informed consent was obtained from all patients. The patients were in left lateral decubitus position during both studies. The studies were performed at resting state and during the Valsalva maneuver after contrast injection. The patients had been trained in performing the Valsalva maneuver before study. The training phase included up to 5 Valsalva maneuver attempts, with at least two resulting in septal shifting or reduced middle cerebral artery flow velocity which was followed by contrast injection and the Valsalva maneuver solicited. The study was repeated at least three times.

Agitated saline contrast test

TCD and TEE examinations were performed according to a standardized procedure. In brief, 10 mL of air-mixed saline was injected into the right antecubital vein at three different times, while the Doppler signal was recorded during the Valsalva maneuver. During TCD the passage of contrast into the right-middle cerebral artery was recorded 25 seconds after the Valsalva maneuver. A mixture of 9 mL physiological saline and 1 mL air was agitated 10 times in 2 10-mL syringes connected to a 3-way stopcock to exchange the air-saline mix and achieve good dilution. The bolus of saline solution was prepared and injected by the same nurse using the same method in all studies. The patients started the maneuver about 5 seconds after contrast injection, pressing against the closed glottis for at least 10 seconds. They then performed a deep expiration and inspiration, followed by a deep expiration.

Transcranial doppler ultrasonography

A baseline TCD examination was performed with a Toshiba Power Vision echo-machine using a 2-MHz probe, according to standard practice guidelines. Middle cerebral artery flow was monitored through the temporal bone window. The middle cerebral artery was identified with color Doppler in its proximal portion and insonated bilaterally (Figure 1). On TCD study, the effectiveness of the Valsalva maneuver was verified by a reduction of the middle cerebral artery flow velocity, in comparison with the basal spectrum. TCD was considered positive if at least one microembolic signal was recorded on TCD spectrum within 25 seconds from contrast injection. The shunt was defined as small (1, 10 microembolic signals), medium (>10 microembolic signals), or large (>10 microembolic signals with “curtain”).

Transesophageal echocardiography

The patients received local pharyngeal anesthesia with 10% topical lidocaine for TEE study. A TEE study was performed using a Toshiba Power Vision machine with a 5.0-MHz multiplane probe, according to a standard protocol including color flow Doppler data. The atrial septum was analyzed from the transverse mid-esophageal four-chamber view to the longitudinal biatrial-bicaval view (Figure 2). Since PFO was not clearly recognized by a bicaval view at 90° rotation, additional image planes (60°, 90° and/or 110°-130°) were used to better analyze the atrial septum. On TEE study, the effectiveness of the Valsalva maneuver was verified by a reduction in right ventricular and atrial size and by bulging of the atrial septum into the left atrium. To assess PFO, semi-quantification of the right to left shunt (RLS) was performed. On TEE the evaluation was based on counting the number of micro bubbles (MBs) moving from the right atrium to the left atrium through the PFO after the Valsalva maneuver, within the first three cardiac cycles. The studies were considered positive for PFO when at least one micro bubble was observed in the left atrium. The severity of the shunt was quantified as mild (<10 micro bubbles), moderate (10–20 micro bubbles), or severe (>20). If the quantitative results varied between the first and second study the largest number of MBs decided about the shunt size.

Statistical analysis

The SPSS 13.0 software package was used for statistical analysis. Quantitative data were expressed as the mean ± standard deviation, qualitative data as the percentage. The performance indexes used were sensitivity, specificity, predictive positive value (PPV), negative predictive value (NPV), and k concordance index, which express the agreement proportion beyond chance.
Sensitivity was defined as:
sentivity = number of True Positives number of True Positives + number of False Negatives
Specificity was defined as:
specificity = number of True Negatives number of True Negatives + number of False Positives

Results

Using both TCD and TEE, we detected a right-to-left shunt in 220 patients (52.3%) and no-shunts in 159 patients (37.9%). In 20 (4.8%) patients TEE did not show the passage of contrast which was later detected by TCD. In 21 (5.0%) patients only TEE revealed a PFO. The feasibility of both methods was 100%. Shunts confirmed by both methods (TCD and TEE) were found in: 78.4% of patients with cryptogenic stroke, in 48.6% of patients with TIA, and only in 10.4% of patients with migraine without aura (Table 2). Considering TEE as the gold standard technique, TCD was able to identify 200 (91.3%) of the 241 patients with PFO. TCD showed a NPV of 89%, PPV of 98%, sensitivity of 95%, and specificity of 92%. TCD showed a high concordance (k = 0.89) with TEE in PFO recognition (Table 3). Shunt grading in both TCD and TEE methods was classified with the same score in 70.5% of cases, and it was the highest in the large shunt (Table 4).
Table 2
Shunt grading using both transcranial doppler ultrasonography and transesophageal echocardiography
SHUNT
TEE (N= 220 pts – TEE and TCD positive)
TCD (N= 220 pts – TEE and TCD positive)
% of the same grading using both methods
Small
56 (25.5%)
70 (31.8%)
62.1
Medium
123 (55.9%)
119 (54.1%)
68.3
Large
41 (18.6%)
31 (14.1%)
83.2
TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography.
Table 3
Identification of persistent for amen ovale using both transcranial color doppler and transesophageal echocardiography
Clinical characteristics of patients
Identification of PFO (both TCD and TEE)
 
Patients (n = 420)
Patients (n = 220)
TIA
218 (51.9%)
106/218 (48.6%)
Migraine
67 (15.6%)
7/67 (10.4%)
Migraine with aura
50 (11.9%)
38/50 (76.0%)
Cryptogenic stroke
88 (20.9%)
69/88 (78.4%)
PFO Patent Foramen Ovale, TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography, TIA Transient Ischaemic Attack.
Table 4
Sensitivity, specificity, negative predictive value, and positive predictive value of transcranial doppler ultrasonography in comparison with transesophageal echocardiography in pfo detection
Technique
PFO (%)
PPV (%)
NPV (%)
Sensitivity (%)
Specificity (%)
Contrast-enhanced TCD
90
98
89
95
92
NPV: Negative Predictive Value, PPV: Negative Predictive Value TCD: Transcranial Doppler Ultrasonography, TEE: Transesophageal Echocardiography, PFO: Patent Foramen Ovale.

Discussion

Patent foramen ovale is a hemodynamically trivial interatrial communication that is present in about 25% of the adult population. However, the clinical significance of PFO in relation to cerebrovascular events is still debated, identification and assessment of this abnormality are nowadays a routine diagnostic procedure [6, 912]. The search for PFO is becoming more and more common in young subjects suffering from migraine, TIA or cryptogenic stroke [1217]. At the moment there is no clearly recognized standard protocol for performing both TEE and TCD studies to identify PFO. For the first time, based on the available literature, we developed a standardized exercise protocol in both TEE and TCD studies.
Contrast transesophageal echocardiography is the gold standard for the diagnosis of PFO, regardless of the fact that this procedure is semi-invasive [1824]. Therefore, transcranial Doppler ultrasonography seems to be an attractive alternative to TEE in the recognition of PFO, because it is a cheap and noninvasive examination [2529].
The aim of this study was to evaluate the feasibility of transcranial Doppler and its diagnostic sensitivity compared with transesophageal echocardiography. Although the diagnostic power of TCD has been reported, only a few studies comparing both techniques (TCD and TEE) have been published [5, 3033]. In our study TCD had a good sensitivity and specificity. In our opinion, in contrast to other investigators, TCD and TEE are complementary for PFO diagnosis, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost, and high feasibility. Contrary to other researchers, our results and clinical experience show that both methods are necessary and complementary to recognize a significant foramen ovale.
The sensitivity and specificity of TCD for shunt detection vary in different studies according to both protocol and diagnostic criteria [2533]. In our study TCD had 89% NPV, 98% PPV, 95% sensitivity, and 92% specificity. In the Caputi study a general concordance of up to 90% between TEE and TCD was found. TCD sensitivity and specificity were 96.8% and 78.4%, respectively [25].
Several studies have suggested that the low specificity of TCD may be due to the fact that TCD is able to detect both cardiac and pulmonary shunts [5]. The specificity for a PFO shunt may be increased by a defined time of micro bubble appearance. The passage time from the antecubital vein injection site to the middle cerebral artery (MCA) through an intracardiac shunt is about 11 seconds, and it is about 14 seconds in the case of pulmonary passage. The overlap interval between intrapulmonary and cardiac passage level must be taken into account [33].
In our study only in 4.8% of patients TEE did not show the passage of contrast which was later detected by TCD. The meaning of a shunt detected only during TCD is not clearly understood, but a very small intracardiac shunt, not detected by TEE, cannot be excluded. Furthermore the Valsalva maneuver may be less effective during TEE than during TCD, because of esophageal intubation. It is crucial to perform the Valsalva maneuver properly. Contrary to other investigators, in our material, the patients had been trained in performing the Valsalva maneuver before study.
Recent studies as well as our results (95% sensitivity, and 92% specificity of TCD), show a good concordance between TCD and TEE with sensitivity ranging from 70% to 100% and specificity >95% [27, 31, 32].
Both techniques have class IIA recommendations for shunt detection [33].
Taking into account that TCD and TEE have similar sensitivity and specificity in shunt detection TCD should be recommended as the first choice for screening because of its low cost, and high feasibility. TCD is also a noninvasive exam - easy to perform and repeat, if necessary. TEE should be limited to the patients scheduled for transcatheter PFO closure, patients with high-risk PFO with recurrent stroke, and patients with ASA or large shunt detected on TCD.

Conclusion

TCD has a relatively good sensitivity and specificity. TCD and TEE are complementary for PFO diagnosis, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost, and high feasibility.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MK: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. MO: contributed to study conception and design, helped to draft the manuscript, revising it critically. TP: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content, gave final approval of the version to be published. JP: contributed to study conception and design, analysis and interpretation of data. JS: analysis and interpretation of data, drafting the manuscript. BS: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript. RB: contributed in revising critically for important intellectual content. AKZ: analysis and interpretation of data, revising it critically for important intellectual content. LTP: contributed in acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. PP: contributed to study conception and design, revising it critically for important intellectual content, gave final approval of the version to be published. All author’s read approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Gupta V, Yesilbursa D, Huang WY, Aggarwal K, Gupta V, Gomez C, Patel V, Miller AP, Nanda NC: Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age distribution, gender, and race. Echocardiography. 2008, 25: 217-227.CrossRefPubMed Gupta V, Yesilbursa D, Huang WY, Aggarwal K, Gupta V, Gomez C, Patel V, Miller AP, Nanda NC: Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age distribution, gender, and race. Echocardiography. 2008, 25: 217-227.CrossRefPubMed
2.
Zurück zum Zitat Carerj S, Narbone MC, Zito C, Serra S, Coglitore S, Pugliatti P, Luzza F, Arrigo F, Oreto G: Prevalence of atrial septal aneurysm in migraine patients: an echocardiographic study. Headache. 2003, 43: 725-728. 10.1046/j.1526-4610.2003.03129.xCrossRefPubMed Carerj S, Narbone MC, Zito C, Serra S, Coglitore S, Pugliatti P, Luzza F, Arrigo F, Oreto G: Prevalence of atrial septal aneurysm in migraine patients: an echocardiographic study. Headache. 2003, 43: 725-728. 10.1046/j.1526-4610.2003.03129.xCrossRefPubMed
3.
Zurück zum Zitat De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG: Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000, 31: 2407-2413. 10.1161/01.STR.31.10.2407CrossRefPubMed De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG: Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000, 31: 2407-2413. 10.1161/01.STR.31.10.2407CrossRefPubMed
4.
Zurück zum Zitat Homma S, Sacco R, Di Tullio M, Sciacca R, Mohr J: Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002, 105: 2625-2631. 10.1161/01.CIR.0000017498.88393.44CrossRefPubMed Homma S, Sacco R, Di Tullio M, Sciacca R, Mohr J: Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002, 105: 2625-2631. 10.1161/01.CIR.0000017498.88393.44CrossRefPubMed
5.
Zurück zum Zitat Khalid MM, Scott RC, Jared WS, Jorge R, David G-M, Rubine G, Tobis JM: Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective stusies. JACC Cardiovas Imaging. 2014, 7 (3): 236-250. 10.1016/j.jcmg.2013.12.011.CrossRef Khalid MM, Scott RC, Jared WS, Jorge R, David G-M, Rubine G, Tobis JM: Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective stusies. JACC Cardiovas Imaging. 2014, 7 (3): 236-250. 10.1016/j.jcmg.2013.12.011.CrossRef
6.
Zurück zum Zitat Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS: Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005, 46: 1768-1776. 10.1016/j.jacc.2005.08.038CrossRefPubMed Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS: Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005, 46: 1768-1776. 10.1016/j.jacc.2005.08.038CrossRefPubMed
7.
Zurück zum Zitat Kerut EK, Norfleet WT, Plotnick GD, Giles TD: Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001, 38: 613-623. 10.1016/S0735-1097(01)01427-9CrossRefPubMed Kerut EK, Norfleet WT, Plotnick GD, Giles TD: Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001, 38: 613-623. 10.1016/S0735-1097(01)01427-9CrossRefPubMed
8.
Zurück zum Zitat Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007, 49: 797-802. 10.1016/j.jacc.2006.08.063CrossRefPubMed Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007, 49: 797-802. 10.1016/j.jacc.2006.08.063CrossRefPubMed
9.
Zurück zum Zitat Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1, 000 consecutive patients. J Am Coll Cardiol. 2004, 43: 302-309. 10.1016/j.jacc.2003.10.030CrossRefPubMed Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1, 000 consecutive patients. J Am Coll Cardiol. 2004, 43: 302-309. 10.1016/j.jacc.2003.10.030CrossRefPubMed
10.
Zurück zum Zitat Woods T, Patel A: A critical review of patent foramen ovale detection using saline contraste echocardiography: when bubbles lie. J Am Soc Echocardiogr. 2006, 19: 215-222. 10.1016/j.echo.2005.09.023CrossRefPubMed Woods T, Patel A: A critical review of patent foramen ovale detection using saline contraste echocardiography: when bubbles lie. J Am Soc Echocardiogr. 2006, 19: 215-222. 10.1016/j.echo.2005.09.023CrossRefPubMed
11.
Zurück zum Zitat Zito C, Dattilo G, Oreto G, Di Bella G, Lamari A, Iudicello R, Trio O, Caracciolo G, Coglitore S, Arrigo F, Carerj S: Patent foramen ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography. 2009, 26: 495-502. 10.1111/j.1540-8175.2008.00852.xCrossRefPubMed Zito C, Dattilo G, Oreto G, Di Bella G, Lamari A, Iudicello R, Trio O, Caracciolo G, Coglitore S, Arrigo F, Carerj S: Patent foramen ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography. 2009, 26: 495-502. 10.1111/j.1540-8175.2008.00852.xCrossRefPubMed
12.
Zurück zum Zitat Hausmann D, Mügge A, Becht I, Daniel WG: Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol. 1992, 70: 668-672. 10.1016/0002-9149(92)90210-PCrossRefPubMed Hausmann D, Mügge A, Becht I, Daniel WG: Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol. 1992, 70: 668-672. 10.1016/0002-9149(92)90210-PCrossRefPubMed
13.
Zurück zum Zitat Kerut EK, Lee S, Fox E: Diagnosis of an anatomically and physiologically significant patent foramen ovale. Echocardiography. 2006, 23: 810-815. 10.1111/j.1540-8175.2006.00318.xCrossRefPubMed Kerut EK, Lee S, Fox E: Diagnosis of an anatomically and physiologically significant patent foramen ovale. Echocardiography. 2006, 23: 810-815. 10.1111/j.1540-8175.2006.00318.xCrossRefPubMed
14.
Zurück zum Zitat Mesa D, Franco M, Suárez de Lezo J, Muñoz J, Rus C, Delgado M: Prevalencia de foramen oval permeable en pacientes jóvenes con accidente isquémico cerebral de causa desconocida. Rev Esp Cardiol. 2003, 56: 662-668. 10.1016/S0300-8932(03)76936-XCrossRefPubMed Mesa D, Franco M, Suárez de Lezo J, Muñoz J, Rus C, Delgado M: Prevalencia de foramen oval permeable en pacientes jóvenes con accidente isquémico cerebral de causa desconocida. Rev Esp Cardiol. 2003, 56: 662-668. 10.1016/S0300-8932(03)76936-XCrossRefPubMed
15.
Zurück zum Zitat Calvert PA, Rana BS, Kydd AC, Shapiro LM: Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol. 2011, 8: 148-160. 10.1038/nrcardio.2010.224CrossRefPubMed Calvert PA, Rana BS, Kydd AC, Shapiro LM: Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol. 2011, 8: 148-160. 10.1038/nrcardio.2010.224CrossRefPubMed
16.
Zurück zum Zitat Hamilton-Craig C, Sestito A, Natale L, Meduri A, Santangeli P, Infusino F, Pilato F, Di Lazzaro V, Crea F, Lanza GA: Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale. Eur J Echocardiogr. 2011, 12: 222-227. 10.1093/ejechocard/jeq177CrossRefPubMed Hamilton-Craig C, Sestito A, Natale L, Meduri A, Santangeli P, Infusino F, Pilato F, Di Lazzaro V, Crea F, Lanza GA: Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale. Eur J Echocardiogr. 2011, 12: 222-227. 10.1093/ejechocard/jeq177CrossRefPubMed
17.
Zurück zum Zitat Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T: Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996, 77: 1202-1209. 10.1016/S0002-9149(96)00163-4CrossRefPubMed Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T: Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996, 77: 1202-1209. 10.1016/S0002-9149(96)00163-4CrossRefPubMed
18.
Zurück zum Zitat Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P: Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism. Eur J Echocardiogr. 2010, 11: 461-476. 10.1093/ejechocard/jeq045CrossRefPubMed Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P: Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism. Eur J Echocardiogr. 2010, 11: 461-476. 10.1093/ejechocard/jeq045CrossRefPubMed
19.
Zurück zum Zitat Kühl HP, Hoffmann R, Merx MW, Franke A, Klötzsch C, Lepper W, Reineke T, Noth J, Hanrath P: Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial to left shunt in patients with cerebral embolic events. J Am Coll Cardiol. 1999, 34: 1823-1830. 10.1016/S0735-1097(99)00412-XCrossRefPubMed Kühl HP, Hoffmann R, Merx MW, Franke A, Klötzsch C, Lepper W, Reineke T, Noth J, Hanrath P: Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial to left shunt in patients with cerebral embolic events. J Am Coll Cardiol. 1999, 34: 1823-1830. 10.1016/S0735-1097(99)00412-XCrossRefPubMed
20.
Zurück zum Zitat Monte I, Grasso S, Licciardi S, Badano LP: Head-to-head of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale. Eur J Echocardiogr. 2010, 11: 245-249. 10.1093/ejechocard/jep195CrossRefPubMed Monte I, Grasso S, Licciardi S, Badano LP: Head-to-head of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale. Eur J Echocardiogr. 2010, 11: 245-249. 10.1093/ejechocard/jep195CrossRefPubMed
21.
Zurück zum Zitat Pearson AC, Labovitz AJ, Tatineni S, Gomez CR: Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991, 17: 66-72. 10.1016/0735-1097(91)90705-ECrossRefPubMed Pearson AC, Labovitz AJ, Tatineni S, Gomez CR: Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991, 17: 66-72. 10.1016/0735-1097(91)90705-ECrossRefPubMed
22.
Zurück zum Zitat Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J: Transesophageal echocardiography findings in stroke subtypes. Stroke. 1994, 25: 23-28. 10.1161/01.STR.25.1.23CrossRefPubMed Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J: Transesophageal echocardiography findings in stroke subtypes. Stroke. 1994, 25: 23-28. 10.1161/01.STR.25.1.23CrossRefPubMed
23.
Zurück zum Zitat Teague SM, Sharma MK: Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke. 1991, 22: 740-745. 10.1161/01.STR.22.6.740CrossRefPubMed Teague SM, Sharma MK: Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke. 1991, 22: 740-745. 10.1161/01.STR.22.6.740CrossRefPubMed
24.
Zurück zum Zitat Devuyst G, Piechowski-Józwiak B, Karapanayiotides T, Fitting JW, Kémeny V, Hirt L, Urbano LA, Arnold P, van Melle G, Despland PA, Bogousslavsky J: Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke. 2004, 35: 859-863. 10.1161/01.STR.0000119384.28376.EBCrossRefPubMed Devuyst G, Piechowski-Józwiak B, Karapanayiotides T, Fitting JW, Kémeny V, Hirt L, Urbano LA, Arnold P, van Melle G, Despland PA, Bogousslavsky J: Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke. 2004, 35: 859-863. 10.1161/01.STR.0000119384.28376.EBCrossRefPubMed
25.
Zurück zum Zitat Caputi L, Carriero MR, Falcone C, Parati E, Piotti P, Materazzo C, Anzola GP: Transcranial Doppler and transesophageal echocardiography: comparison of both techniques and prospective clinical relevance of transcranial Doppler in patent foramen ovale detection. J Stroke Cerebrovasc Dis. 2009, 18: 343-348. 10.1016/j.jstrokecerebrovasdis.2008.12.001CrossRefPubMed Caputi L, Carriero MR, Falcone C, Parati E, Piotti P, Materazzo C, Anzola GP: Transcranial Doppler and transesophageal echocardiography: comparison of both techniques and prospective clinical relevance of transcranial Doppler in patent foramen ovale detection. J Stroke Cerebrovasc Dis. 2009, 18: 343-348. 10.1016/j.jstrokecerebrovasdis.2008.12.001CrossRefPubMed
26.
Zurück zum Zitat Klötzsch C, Janssen G, Berlit P: Transesophageal echocardiography and contrast TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology. 1994, 44: 1603-1606. 10.1212/WNL.44.9.1603CrossRefPubMed Klötzsch C, Janssen G, Berlit P: Transesophageal echocardiography and contrast TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology. 1994, 44: 1603-1606. 10.1212/WNL.44.9.1603CrossRefPubMed
27.
Zurück zum Zitat Devuyst G, Despland PA, Bogousslavsky J, Jeanrenaud X: Complementarity of contrast transcranial Doppler and contrast transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur Neurol. 1997, 38: 21-25.CrossRefPubMed Devuyst G, Despland PA, Bogousslavsky J, Jeanrenaud X: Complementarity of contrast transcranial Doppler and contrast transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur Neurol. 1997, 38: 21-25.CrossRefPubMed
28.
Zurück zum Zitat Souteyrand G, Motreff P, Lusson JR, Rodriguez R, Geoffroy E, Dauphin C, Boire JY, Lamaison D, Cassagnes J: Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr. 2006, 7: 147-154. 10.1016/j.euje.2005.04.007CrossRefPubMed Souteyrand G, Motreff P, Lusson JR, Rodriguez R, Geoffroy E, Dauphin C, Boire JY, Lamaison D, Cassagnes J: Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr. 2006, 7: 147-154. 10.1016/j.euje.2005.04.007CrossRefPubMed
29.
Zurück zum Zitat Droste DW, Lakemeier S, Wichter T, Stypmann J, Dittrich R, Ritter M: Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002, 33: 2211-2216. 10.1161/01.STR.0000027884.03365.ACCrossRefPubMed Droste DW, Lakemeier S, Wichter T, Stypmann J, Dittrich R, Ritter M: Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002, 33: 2211-2216. 10.1161/01.STR.0000027884.03365.ACCrossRefPubMed
30.
Zurück zum Zitat Van H, Poommipanit P, Shalaby M, Gevorgyan R, Tseng CH, Tobis J: Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt. JACC Cardiovasc Imaging. 2010, 3: 343-348.CrossRefPubMedPubMedCentral Van H, Poommipanit P, Shalaby M, Gevorgyan R, Tseng CH, Tobis J: Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt. JACC Cardiovasc Imaging. 2010, 3: 343-348.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ: Interatrial septal mobility predicts larger shunts across patent foramen ovale: An analysis with transmitral Doppler scanning. Am Heart J. 2003, 145: 730-736. 10.1067/mhj.2003.5CrossRefPubMed Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ: Interatrial septal mobility predicts larger shunts across patent foramen ovale: An analysis with transmitral Doppler scanning. Am Heart J. 2003, 145: 730-736. 10.1067/mhj.2003.5CrossRefPubMed
32.
Zurück zum Zitat Droste DW, Silling K, Stypmann J, Grude M, Kemény V, Wichter T, Kühne K, Ringelstein EB: Contrast transcranial Doppler ultrasound in the detection of right to left shunts: Time window and threshold in microbubble numbers. Stroke. 2000, 31: 1640-1645. 10.1161/01.STR.31.7.1640CrossRefPubMed Droste DW, Silling K, Stypmann J, Grude M, Kemény V, Wichter T, Kühne K, Ringelstein EB: Contrast transcranial Doppler ultrasound in the detection of right to left shunts: Time window and threshold in microbubble numbers. Stroke. 2000, 31: 1640-1645. 10.1161/01.STR.31.7.1640CrossRefPubMed
33.
Zurück zum Zitat Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL, Lefkowitz D, Goldman RS, Armon C, Hsu CY: Goodin DS Assessment: Transcranial Doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2008, 62: 1468-1481.CrossRef Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL, Lefkowitz D, Goldman RS, Armon C, Hsu CY: Goodin DS Assessment: Transcranial Doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2008, 62: 1468-1481.CrossRef
Metadaten
Titel
Transcranial doppler ultrasonography should it be the first choice for persistent foramen ovale screening?
verfasst von
Monika Komar
Maria Olszowska
Tadeusz Przewłocki
Jakub Podolec
Jakub Stępniewski
Bartosz Sobień
Rafał Badacz
Anna Kabłak-Ziembicka
Lidia Tomkiewicz-Pająk
Piotr Podolec
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
Cardiovascular Ultrasound / Ausgabe 1/2014
Elektronische ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-12-16

Weitere Artikel der Ausgabe 1/2014

Cardiovascular Ultrasound 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.